SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-032481
Filing Date
2018-05-11
Accepted
2018-05-11 14:30:29
Documents
3
Effectiveness Date
2018-05-11

Document Format Files

Seq Description Document Type Size
1 DEFA 14A a18-11294_3defa14a.htm DEFA14A 49927
2 GRAPHIC g112943bci001.jpg GRAPHIC 4584
3 GRAPHIC g112943bci002.jpg GRAPHIC 945
  Complete submission text file 0001104659-18-032481.txt   58838
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32966 | Film No.: 18826359
SIC: 2836 Biological Products, (No Diagnostic Substances)